Mantle cell lymphoma (MCL) is a complex disease with various subtypes, including classical and leukemic variants. These subtypes exhibit different clinical behaviors and affect different parts of the body, such as lymph nodes, blood, or bone marrow. The disease's progression and aggressiveness vary significantly among patients, influenced by genetic factors and molecular markers.
Research aims to improve understanding and treatment options for MCL. Studies focus on enhancing diagnosis and therapy strategies to address the diverse manifestations of the disease. This includes exploring how different subtypes respond to treatment and how genetic changes impact disease progression, as noted in recent publications like O'Leary (2024).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
